Company Filing History:
1 out of 9 
1 out of 96 
1 out of 10 Years Active: 2019-2023
Title: Innovator Wenke Wagner: Pioneering RNA Composition Methods
Introduction: Wenke Wagner, a noteworthy inventor based in Reutlingen, Germany, has made significant contributions to pharmaceutical applications through his innovative methods involving RNA compositions. With a total of three patents, his work focuses on advancing the medical field, particularly in the development of vaccines and medicaments.
Latest Patents: One of Wenke Wagner's most recent patents is a method for producing RNA compositions, which involves creating a liquid composition that includes a nanoparticle containing at least one RNA molecule and at least one cationic or polycationic compound. This method is notable for its scalability, making it suitable for pharmaceutical applications. The patent also emphasizes the application of this method in manufacturing medications and vaccines, as well as detailing the compositions that contain RNA-comprising nanoparticles and the pharmaceutical compositions derived from them.
Career Highlights: Throughout his career, Wenke has held key positions in various organizations, most notably at Curevac Real Estate GmbH and Curevac AG. His expertise in RNA technology and its applications demonstrates his commitment to leveraging innovative solutions in the healthcare sector.
Collaborations: In his professional journey, Wenke has collaborated with esteemed colleagues, including Stefanie Sewing and Fabian Johannes Eber, contributing to a dynamic work environment that fosters creativity and innovation in the field of pharmaceutical research.
Conclusion: Wenke Wagner continues to push the boundaries of pharmaceutical innovation with his groundbreaking work in RNA compositions. His patents not only reflect his inventive spirit but also hold promise for significant advancements in medication and vaccine development. As he continues to collaborate with experts in the field, the potential for future innovations remains vast.